Sanofi Pasteur, Sanofi’s vaccines unit, said on Tuesday that its dengue vaccine, Dengvaxia, had received market approval in eleven countries. To date the vaccine has been approved in Mexico, the Philippines, Brazil, El Salvador, Costa Rica, Paraguay, Guatemala, Peru, Indonesia, Thailand and Singapore, the statement said. Read more. Source: Reuters